Get started
Tenaya Therapeutics, Inc.Tenaya Therapeutics, Inc.Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

TNYA chart


Full chart

TNYA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪125.96 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.48 USD
Net income (FY)
‪−124.08 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪65.64 M‬
Beta (1Y)
4.27

Employees


Employees (FY)
140
Change (1Y)
−1 −0.71%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−886.31 K‬ USD

About Tenaya Therapeutics, Inc.


Sector
Health Technology
CEO
Faraz Ali
Headquarters
South San Francisco
Website
tenayatherapeutics.com
Founded
2016
FIGI
BBG00FPMK2S3
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

TNYA news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TNYA is 1.66 USD — it has increased by 4.40% in the past 24 hours. Watch Tenaya Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tenaya Therapeutics, Inc. stocks are traded under the ticker TNYA.
TNYA stock has fallen by −17.00% compared to the previous week, the month change is a −23.15% fall, over the last year Tenaya Therapeutics, Inc. has showed a −38.29% decrease.
We've gathered analysts' opinions on Tenaya Therapeutics, Inc. future price: according to them, TNYA price has a max estimate of 40.00 USD and a min estimate of 6.00 USD. Watch TNYA chart and read a more detailed Tenaya Therapeutics, Inc. stock forecast: see what analysts think of Tenaya Therapeutics, Inc. and suggest that you do with its stocks.
TNYA reached its all-time high on Nov 8, 2021 with the price of 32.00 USD, and its all-time low was 0.99 USD and was reached on Dec 17, 2024. View more price dynamics on TNYA chart.
See other stocks reaching their highest and lowest prices.
TNYA stock is 10.67% volatile and has beta coefficient of 4.27. Track Tenaya Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Tenaya Therapeutics, Inc. there?
Today Tenaya Therapeutics, Inc. has the market capitalization of ‪125.96 M‬, it has decreased by −61.48% over the last week.
Yes, you can track Tenaya Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Tenaya Therapeutics, Inc. is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
TNYA earnings for the last quarter are −0.30 USD per share, whereas the estimation was −0.37 USD resulting in a 18.37% surprise. The estimated earnings for the next quarter are −0.31 USD per share. See more details about Tenaya Therapeutics, Inc. earnings.
Tenaya Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
TNYA net income for the last quarter is ‪−25.63 M‬ USD, while the quarter before that showed ‪−29.43 M‬ USD of net income which accounts for 12.90% change. Track more Tenaya Therapeutics, Inc. financial stats to get the full picture.
No, TNYA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 140.00 employees. See our rating of the largest employees — is Tenaya Therapeutics, Inc. on this list?
Like other stocks, TNYA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tenaya Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tenaya Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tenaya Therapeutics, Inc. stock shows the sell signal. See more of Tenaya Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.